Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
A phosphorylation switch governs KIF11's mechanical output during mitosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 11, 2026
Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomas.
Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026
A Phosphorylation Switch Governs KIF11's Mechanical Output During Mitosis.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Rethinking the role of synergy calculations in the next century of drug combination discovery.
Journal: Med (New York, N.Y.)
Published: October 22, 2025
Glioblastoma Subtypes Exhibit Distinct Migration Mechanics and Immune Responses.
Journal: Cancer research communications
Published: September 21, 2025
Non-muscle myosin II is a promising therapeutic target.
Journal: Trends in pharmacological sciences
Published: August 03, 2025
Predictors of return to work following surgery in patients with glioblastoma: a retrospective multicenter study.
Journal: Journal of neuro-oncology
Published: April 02, 2025
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma.
Journal: Cell
Published: September 24, 2024
Resistance to spindle inhibitors in glioblastoma depends on STAT3 and therapy induced senescence.
Journal: iScience
Published: June 20, 2024
Resistance to Spindle Inhibitors in Glioblastoma Depends on STAT3 and Therapy Induced Senescence.
Journal: bioRxiv : the preprint server for biology
Published: June 19, 2024
MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: May 15, 2024
Last Updated: 09/26/2026